Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Bayer will begin clinical trials of IL-4 antagonist for asthma

Aug. 12, 1999

Bayer reveals antiinflammatory PDE4 inhibitors in patent literature

Aug. 10, 1999

Medeva acquires additional European rights to ML Laboratories' MDPI device

Aug. 10, 1999

Novel PAF antagonist CPR-3005 claimed in patent literature by Clarion

Aug. 9, 1999

Novel cell adhesion inhibitors prepared by Rhone-Poulenc Rorer

Aug. 6, 1999

Discovery Laboratories begins phase II tyloxapol trial in cystic fibrosis

Aug. 6, 1999

Aeolus receives notice of allowance for U.S. patent covering synthetic SOD mimetics

Aug. 3, 1999

International patent recently published covering AstraZeneca PKC inhibitors

July 28, 1999

Heterocyclic compounds as potent and selective NK2 antagonists

July 28, 1999

BM-113: pharmacokinetics and metabolism in rats following oral and intravenous dosing

July 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...